<DOC>
	<DOCNO>NCT00648895</DOCNO>
	<brief_summary>The study design compare effect nebivolol ( 10 , 20 , 40mg/day ) another beta blocker , extended-release metoprolol , range dos . Its purpose study mechanism action nebivolol forearm blood flow , nitric oxide availability biomarkers .</brief_summary>
	<brief_title>A Study Effect Nebivolol Evaluate Its Vasodilatory Effects Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Male female , ambulatory outpatient 1879 year old screen Minimum 2year history Stage I/II hypertension Qualifying blood pressure criterion study entry randomization Willing adhere dietary compliance undergo protocol procedure Have lifestyle permit him/her attend evaluation , include conduct consecutive day Have form secondary hypertension Have clinically significant respiratory cardiovascular disease Presence/history coronary artery disease peripheral vascular disease Have diabetes mellitus , Type I II Have history hypersensitivity nebivolol , metoprolol , betablocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Nebivolol</keyword>
	<keyword>Bystolic ( TM )</keyword>
	<keyword>Metoprolol ER ( TM )</keyword>
</DOC>